Results 261 to 270 of about 52,343 (282)
Some of the next articles are maybe not open access.
Pharmacogenomics, 2005
Sarcomas are a heterogeneous group of tumors, requiring different chemotherapeutic approaches. Recently, several regimens for metastatic tumors were evaluated with respect to the different responses to conventional chemotherapy of the various histologic subtypes of sarcomas.
Paola Biason, Giuseppe Toffoli
openaire +3 more sources
Sarcomas are a heterogeneous group of tumors, requiring different chemotherapeutic approaches. Recently, several regimens for metastatic tumors were evaluated with respect to the different responses to conventional chemotherapy of the various histologic subtypes of sarcomas.
Paola Biason, Giuseppe Toffoli
openaire +3 more sources
Venlafaxine pharmacogenetics: a comprehensive review.
Pharmacogenomics (London), 2019Antidepressant response could be from 42 to 50% genetically determined. Venlafaxine (VEN) was the sixth most-prescribed antidepressant in the USA in 2017. Therefore, we reviewed studies which focused on the pharmacogenetics of VEN and found that there is
J. Suwała +2 more
semanticscholar +1 more source
Pharmacogenetics and psychopharmacology
Current Opinion in Pharmacology, 2004Genetic factors play a major role in the differential responses to treatment or the incidence of adverse drug effects in psychopharmacotherapy. The aim of pharmacogenetics is to elucidate this variability caused by hereditary differences. From hypotheses on the mechanisms of drug action, several mutations in genes coding for neurotransmitter receptors,
Brigitta Bondy, Peter Zill
openaire +3 more sources
Pharmacogenetics and the Fetus
New England Journal of Medicine, 1982It is well accepted in clinical medicine that there is wide variation between patients in the handling of and response to drugs; these differences are based in part on genetic mechanisms. Pharmacogenetic differences among patients contribute to altered drug kinetics, resulting in failure of therapy or in side effects related to blood levels after ...
openaire +3 more sources
Depression and Pharmacogenetics
Archives of Psychiatric Nursing, 2018Depression is the most common and leading devastating psychiatric illness that affects a majority of the world population. The treatment of depression has been a challenge for a majority of patients and healthcare practitioners. The advent of pharmacogenomics (PGx) empowered the Food and Drug Administration to approve some antidepressant biomarkers for
openaire +2 more sources
[Pharmacogenetics of immunosuppressants].
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2015Individualized drug therapy with immunosuppressants is an hot topic in transplantation. Therapeutic drug monitoring (TDM) is currently utilized to guide therapy, but toxic or subtherapeutic concentrations can only be identified after the drug is administered.
Cojutti P. G., Baraldo M.
openaire +3 more sources
2008
Asthma is a common disease characterized by airway inflammation and bronchorestriction. There are several common categories of medications for treating asthma; however, not all asthmatics have the same response to these medications, some of which are adverse responses that are potentially life threatening.
Stephen P. Peters, Gregory A. Hawkins
openaire +3 more sources
Asthma is a common disease characterized by airway inflammation and bronchorestriction. There are several common categories of medications for treating asthma; however, not all asthmatics have the same response to these medications, some of which are adverse responses that are potentially life threatening.
Stephen P. Peters, Gregory A. Hawkins
openaire +3 more sources